Joysoual, M.R. et al. 2026. Safety of Empagliflozin as Add-on Therapy in Patients with Uncontrolled Type 2 Diabetes Mellitus. KYAMC Journal. 16, 3 (Jun. 2026), 119–122. DOI:https://doi.org/10.3329/kyamcj.v16i3.88022.